The application of PCR amplification and the polymorphic marker KM.19 to dried blood spots: Comparison with deletion 508 for the confirmation of the neonatal screening test for cystic fibrosis
- 1 January 1991
- journal article
- Published by Wiley in Pediatric Pulmonology
- Vol. 11 (S7), 19-22
- https://doi.org/10.1002/ppul.1950110705
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Identification of the Cystic Fibrosis Gene: Chromosome Walking and JumpingScience, 1989
- Identification of the Cystic Fibrosis Gene: Genetic AnalysisScience, 1989
- Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNAScience, 1989
- Confirmation of linkage disequilibrium between haplotype B (XV-2c, allele 1; KM-19, allele 2) and cystic fibrosis allele in the French populationHuman Genetics, 1989
- GUTHRIE CARDS FOR DETECTION OF POINT MUTATIONS IN PHENYLKETONURIAThe Lancet, 1988
- PRENATAL DIAGNOSIS OF CYSTIC FIBROSIS BY DNA AMPLIFICATION FOR DETECTION OF KM-19 POLYMORPHISMThe Lancet, 1988
- Patterns of polymorphism and linkage disequilibrium for cystic fibrosisGenomics, 1987
- DRIED-BLOOD SPOT SCREENING FOR CYSTIC FIBROSIS IN THE NEWBORNThe Lancet, 1979